It's testing whether existing medicines used for other conditions could also be useful in treating Covid-19. About 2,100 patients received a 6mg daily dose of dexamethasone in the trial for 10 days.
Toxic epidermal necrolysis possible with thalidomide. Concomitant indomethacin: may get false-negative on dexamethasone suppression test. May suppress reactions to skin tests. HPA axis suppression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback